Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure.

MLA

Prébet, Thomas, et al. “Outcome of Acute Myeloid Leukaemia Following Myelodysplastic Syndrome after Azacitidine Treatment Failure.” British Journal of Haematology, vol. 157, no. 6, June 2012, pp. 764–66. EBSCOhost, https://doi.org/10.1111/j.1365-2141.2012.09076.x.

APA

Prébet, T., Gore, S. D., Thépot, S., Esterni, B., Quesnel, B., Beyne Rauzy, O., Dreyfus, F., Gardin, C., Fenaux, P., & Vey, N. (2012). Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure. British Journal of Haematology, 157(6), 764–766. https://doi.org/10.1111/j.1365-2141.2012.09076.x

Chicago

Prébet, Thomas, Steven D. Gore, Sylvain Thépot, Benjamin Esterni, Bruno Quesnel, Odile Beyne Rauzy, François Dreyfus, Claude Gardin, Pierre Fenaux, and Norbert Vey. 2012. “Outcome of Acute Myeloid Leukaemia Following Myelodysplastic Syndrome after Azacitidine Treatment Failure.” British Journal of Haematology 157 (6): 764–66. doi:10.1111/j.1365-2141.2012.09076.x.